Current Ratio in % of Chemomab Therapeutics Ltd. from Q3 2020 to Q2 2023

Taxonomy & unit: ratio: %
Description: The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary: Chemomab Therapeutics Ltd. quarterly Current Ratio history and change rate from Q3 2020 to Q2 2023.
Chemomab Therapeutics Ltd. Current Ratio for the quarter ending 30 Jun 2023 was 583 %, a 70.7% decline year-over-year.

Current Ratio, Quarterly (%)

Current Ratio, YoY Quarterly Change (%)

Chemomab Therapeutics Ltd. Quarterly Current Ratio (%)

Period	Value	YoY Chg	Change %	Date
Q2 2023	583	-1.41K	-70.7%	30 Jun 2023
Q1 2023	758	-1.82K	-70.6%	31 Mar 2023
Q4 2022	1.02K	-1.3K	-56.2%	31 Dec 2022
Q3 2022	1.41K	-710	-33.5%	30 Sep 2022
Q2 2022	1.99K	+569	+40%	30 Jun 2022
Q1 2022	2.58K	+1.69K	+191%	31 Mar 2022
Q4 2021	2.32K	+1.83K	+369%	31 Dec 2021
Q3 2021	2.12K	+1.69K	+392%	30 Sep 2021
Q2 2021	1.42K			30 Jun 2021
Q1 2021	887			31 Mar 2021
Q4 2020	494			31 Dec 2020
Q3 2020	430			30 Sep 2020

* An asterisk sign (*) next to the value indicates that the value is likely invalid.